Inventor
RENNIE PAUL S
CA13 patents
⚠️ This page may combine multiple inventors who share the name “RENNIE PAUL S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV BRITISH COLUMBIA
9 patentsUS7732422B2Jun 8, 2010
TRPM-2 antisense therapy
UNIV BRITISH COLUMBIA125 citations98
US7368436B2May 6, 2008
TRPM-2 antisense therapy
UNIV BRITISH COLUMBIA35 citations95
US7592323B1Sep 22, 2009
TRPM-2 antisense therapy
UNIV BRITISH COLUMBIA14 citations92
US7534773B1May 19, 2009
TRPM-2 antisense therapy
UNIV BRITISH COLUMBIA11 citations92
US6900187B2May 31, 2005
TRPM-2 antisense therapy using an oligonucleotide having 2′-O-(2-methoxy)ethyl modifications
UNIV BRITISH COLUMBIA37 citations92
US7569551B2Aug 4, 2009
Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
UNIV BRITISH COLUMBIA13 citations88
US7196067B2Mar 27, 2007
Antisense insulin-like growth factor binding protein (IGFBP)-2-oligodeoxynucleotides for prostate and other endocrine tumor therapy
UNIV BRITISH COLUMBIA13 citations80
US8361981B2Jan 29, 2013
Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
UNIV BRITISH COLUMBIA4 citations72
US12017975B2Jun 25, 2024
Myc-Max inhibitor compound therapeutics for cancer treatment, methods and uses associated therewith
UNIV BRITISH COLUMBIA0 citations48
GLEAVE MARTIN
4 patentsUS8173615B2May 8, 2012
TRPM-2 antisense therapy
GLEAVE MARTIN7 citations83
US9095602B2Aug 4, 2015
Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
GLEAVE MARTIN7 citations82
US8536149B2Sep 17, 2013
TRPM-2 antisense therapy
GLEAVE MARTIN3 citations73
US9074209B2Jul 7, 2015
TRPM-2 antisense therapy
GLEAVE MARTIN1 citations62